NCT06467097View on ClinicalTrials.gov

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

February 13, 2031

Study Completion Date

February 13, 2031

Conditions
Kidney Neoplasm
Interventions
RADIATION

SBRT(Stereotatic Body Radiation Therapy)

Patients will receive treatment for one to two weeks, one to five times per region.

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER